Shining Light on Treatments: A Systematic Review of Existing Therapies for Pediatric Segmental Vitiligo
Pediatric Dermatology · 2026
DOI: 10.1111/pde.70215 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pediatric Dermatology, 2026. Verfasst von Hira Ghani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Vitiligo, Phototherapy. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Vitiligo is a common depigmenting disorder affecting 0.5%–2% of the global population, primarily presenting as segmental (SV) or non‐segmental vitiligo (NSV). SV accounts for 3.5%–20.5% of cases, characterized by a rapid yet stable course and reduced responsiveness to conventional therapies. Managing pediatric SV remains challenging. This systematic review assesses the safety and efficacy of current and emerging treatments for pediatric SV over the past decade.
Methods
A systematic literature search was conducted in PubMed, Embase, Cochrane, and Scopus from March to April 2025, following PRISMA 2020 guidelines. Two independent reviewers screened studies, with a third resolving disagreements. Included studies were randomized controlled trials, case reports, case series, and cohort studies on pediatric SV treatments published within the last 10 years.
Results
From 1107 records, 10 studies met inclusion criteria, comprising 2085 pediatric patients (843 with SV). Treatments varied and included autologous cultured epithelium grafting (ACEG), melanocyte–keratinocyte transplantation procedures (MKTP), phototherapy, and topical immunosuppressants. Repigmentation rates varied, with some studies reporting over 70% repigmentation, especially in facial lesions. Adverse events were generally mild, mostly limited to erythema, burning, blistering, and irritation; one infection occurred post‐ACEG. Most studies demonstrated moderate‐to‐low evidence quality and moderate risk of bias.
Conclusion
Early intervention with topical calcineurin inhibitors, corticosteroids, and phototherapy can achieve moderate repigmentation in pediatric SV. In stable disease, surgical modalities such as MKTP and ACEG demonstrate the highest efficacy, while emerging therapies including topical Janus‐kinase (JAK) inhibitors show promising potential pending further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
- Jacobs School of Medicine and Biomedical Sciences at the University of Buffalo, Buffalo, New York, USA.
- The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
ORCID-Profile: Hira Ghani, Asghar Shah, Lionel Bercovitch
Zitieren
APA
Ghani, H., Hoffman, V., Shah, A., Abrantes, T., & Bercovitch, L. (2026). Shining Light on Treatments: A Systematic Review of Existing Therapies for Pediatric Segmental Vitiligo. Pediatric Dermatology. https://doi.org/10.1111/pde.70215
Vancouver
Ghani H, Hoffman V, Shah A, Abrantes T, Bercovitch L. Shining Light on Treatments: A Systematic Review of Existing Therapies for Pediatric Segmental Vitiligo. Pediatric Dermatology. 2026. doi:10.1111/pde.70215
BibTeX
@article{Ghani2026,
author = {Ghani, Hira and Hoffman, Victoria and Shah, Asghar and Abrantes, Tatiana and Bercovitch, Lionel},
title = {Shining Light on Treatments: A Systematic Review of Existing Therapies for Pediatric Segmental Vitiligo},
journal = {Pediatric Dermatology},
year = {2026},
doi = {10.1111/pde.70215}
}
EUVIMED